Analysis - by Product Type (General and Disease Specific), Application (Gastrointestinal Disorders, Metabolic/Inborn Errors of Metabolism, Food Allergy, Renal Disease, Liver Disease, Oncology, Neurology, and Others), Age Group (Adult and Pediatric), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
No. of Pages:
121
|
Report Code:
BMIRE00029864
|
Category:
Life Sciences
The Asia Pacific enteral nutrition market was valued at US$ 1,791.10 million in 2022 and is expected to reach US$ 2,942.72 million by 2030; it is estimated to grow at a CAGR of 6.4% from 2022 to 2030.
Strategic Initiatives by Key Market Players Fuel Asia Pacific Enteral Nutrition Market
Companies operating in the enteral nutrition market continuously focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches. These help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the enteral nutrition market are mentioned below:
- In June 2022, Nestle Health Science acquired The Better Health Company (TBHC) from CDH Investments and TBHC's founding shareholders. The acquisition includes the GO Healthy brand; vitamin and supplement lineups; Egmont, the Manuka honey brand; and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins, minerals, and supplements. The acquisition helped Nestle Health Science strengthen and expand its presence in New Zealand, Australia, and other Asia Pacific countries.
- In September 2021, Abbott introduced plant-based protein and organic food ingredients-PediaSure Harvest and Ensure Harvest-for people relying on feeding tubes. Harvest products can be used as sole-source nutrition or a supplement to satisfy daily nutrition requirements.
- In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company brings unique and nutritious choices to children and adults dependent on feeding tubes, in line with its real food blends mission.
- Therefore, introducing products such as ready-to-drink and ready-to-use nutritional supplements, the development of innovative products targeting various health issues, and strategic moves such as expansions and acquisitions allow companies in the enteral nutrition market to create new or improved products and new business to remain competitive in the market. Thus, such strategic growth initiatives create significant growth opportunities in the market.
Asia Pacific Enteral Nutrition Market Overview
The Asia Pacific enteral nutrition market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. Countries such as Australia, India, and South Korea are estimated to witness various growth opportunities due to the rising development in the healthcare sector. In addition, governments of these countries are increasing their efforts to provide enteral and parenteral nutrition.
The rising prevalence of neurological diseases and the growing adoption of enteral nutrition are boosting the market's growth. China has experienced a significant rise in the elderly population. Stroke is the leading cause of death among older people across the country. According to the study published in Elsevier, in 2020, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported. The factors that have affected the numbers are the support of the government to educate the public on stroke prevention, better public knowledge of stroke, improved treatment options and medical technology, and improved healthcare coverage and healthcare environment, among others. Stroke is the most common cause of acute dysphagia, which may lead to malnutrition and impact the quality of life. Tube feeding of critically ill stroke patients was implemented as an enteral nutrition improvement strategy in China.
Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Enteral Nutrition Market Segmentation
The Asia Pacific enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.
Based on product type, the Asia Pacific enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Asia Pacific enteral nutrition market share in 2022.
In terms of application, the Asia Pacific enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Asia Pacific enteral nutrition market share in 2022.
Based on age group, the Asia Pacific enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Asia Pacific enteral nutrition market share in 2022.
By distribution channel, the Asia Pacific enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Asia Pacific enteral nutrition market share in 2022.
Based on country, the Asia Pacific enteral nutrition market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific enteral nutrition market in 2022.
Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Reckitt Benckiser Group Plc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the Asia Pacific enteral nutrition market.
Asia Pacific Enteral Nutrition Strategic Insights
Strategic insights for the Asia Pacific Enteral Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Get more information on this report
Asia Pacific Enteral Nutrition Report Scope
Report Attribute
Details
Market size in 2022
US$ 1,791.10 Million
Market Size by 2030
US$ 2,942.72 Million
Global CAGR (2022 - 2030)
6.4%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Product Type
General
Disease Specific
By Application
Gastrointestinal Disorders
Metabolic/Inborn Errors of Metabolism
Food Allergy
Renal Disease
Liver Disease
Oncology
Neurology
By Age Group
Adult
Pediatric
By Distribution Channel
Hospital Pharmacies
Retail Stores
E-Commerce
Regions and Countries Covered
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Market leaders and key company profiles
Abbott Laboratories
Arla Foods amba
B Braun SE
Danone SA
Fonterra Co-Operative Group Ltd
Fresenius SE & Co KGaA
Nestle SA
Perrigo Co Plc
Reckitt Benckiser Group Plc
Royal FrieslandCampina NV
Get more information on this report
Asia Pacific Enteral Nutrition Regional Insights
The geographic scope of the Asia Pacific Enteral Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Asia Pacific Enteral Nutrition Market
1. Abbott Laboratories
2. Arla Foods amba
3. B Braun SE
4. Danone SA
5. Fonterra Co-Operative Group Ltd
6. Fresenius SE & Co KGaA
7. Nestle SA
8. Perrigo Co Plc
9. Reckitt Benckiser Group Plc
10. Royal FrieslandCampina NV
Frequently Asked Questions
How big is the Asia Pacific Enteral Nutrition Market?
The Asia Pacific Enteral Nutrition Market is valued at US$ 1,791.10 Million in 2022, it is projected to reach US$ 2,942.72 Million by 2030.
What is the CAGR for Asia Pacific Enteral Nutrition Market by (2022 - 2030)?
As per our report Asia Pacific Enteral Nutrition Market, the market size is valued at US$ 1,791.10 Million in 2022, projecting it to reach US$ 2,942.72 Million by 2030. This translates to a CAGR of approximately 6.4% during the forecast period.
What segments are covered in this report?
The Asia Pacific Enteral Nutrition Market report typically cover these key segments-
Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce)
What is the historic period, base year, and forecast period taken for Asia Pacific Enteral Nutrition Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Enteral Nutrition Market report:
Historic Period : 2020-2021
Base Year : 2022
Forecast Period : 2023-2030
Who are the major players in Asia Pacific Enteral Nutrition Market?
The Asia Pacific Enteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Abbott Laboratories
Arla Foods amba
B Braun SE
Danone SA
Fonterra Co-Operative Group Ltd
Fresenius SE & Co KGaA
Nestle SA
Perrigo Co Plc
Reckitt Benckiser Group Plc
Royal FrieslandCampina NV
Who should buy this report?
The Asia Pacific Enteral Nutrition Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Asia Pacific Enteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Asia Pacific Enteral Nutrition Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines